Zobrazeno 1 - 10
of 171
pro vyhledávání: '"V V, Arkhipov"'
Publikováno v:
Безопасность и риск фармакотерапии, Vol 12, Iss 2, Pp 132-154 (2024)
INTRODUCTION. Pharmacogenetic (PGx) testing plays a significant role in predicting the risk of adverse drug reactions (ADRs) associated with valproic acid (VPA) products, which are among the most prescribed medicinal products in neurology and psychia
Externí odkaz:
https://doaj.org/article/32c6ea0e49e5483e87a4e211daaad892
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 4, Pp 450-462 (2023)
Scientific relevance. Valproic acid (VPA) is a psychotropic medicinal product, which may be associated with serious adverse drug reactions (ADRs). While pharmacogenetics and pharmacometabolomics can significantly affect the safety of valproates, ther
Externí odkaz:
https://doaj.org/article/6713f4b9ad574e72af3d291479693687
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 3, Pp 348-360 (2023)
Scientific relevance. Epileptic syndromes associated with focal seizures often develop in children and adolescents and may be accompanied by cognitive impairment, mental disorders, and endocrine disorders, which require additional medication apart fr
Externí odkaz:
https://doaj.org/article/90a03465fee74ba985b326d06a333d9e
Autor:
Yu. R. Bolsunovskaya, V. V. Arkhipov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 4, Pp 411-419 (2022)
The state policy for the safety of medicinal products involves analysis of specialists' competence in identifying adverse drug reactions (ADRs) during the use of medicinal products. It is of particular importance for the group of essential medicines,
Externí odkaz:
https://doaj.org/article/75cb790bcff74684b203c864eb60e0a8
Autor:
M. M. Tanashyan, N. A. Shamalov, I. A. Voznyuk, S. N. Yanishevsky, O. I. Vinogradov, D. R. Khasanova, O. V. Tikhomirova, V. A. Parfenov, E. V. Oshchepkova, M. V. Ezhov, V. S. Gurevich, V. V. Arkhipov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 4, Pp 108-113 (2022)
On July 6, 2022, an interdisciplinary meeting of the Expert Council was held on the topic "Control of dyslipidemia in the prevention of acute and recurrent ischemic cerebrovascular accidents". The conclusion of the Expert Council was that after verif
Externí odkaz:
https://doaj.org/article/5131cf7e37dc4328a08303b97dcf28e3
Autor:
E. A. Sokova, V. V. Arkhipov, A. S. Kazakov, B. K. Romanov, R. N. Alyautdin, M. V. Zhuravleva
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 2, Pp 110-117 (2022)
Aztreonam is the only approved monocyclic β-lactam antibiotic for human use that is active against Gram-negative aerobes, primarily Pseudomonas аeruginosa. Aztreonam has been used for more than 35 years, and aztreonam lysine has been on the market
Externí odkaz:
https://doaj.org/article/a77fbae6300d4640a1140181d0a07218
Autor:
V. V. Arkhipov, N. I. Burmistrova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 2, Pp 151-160 (2022)
Epilepsy is a fairly common disease which challenges social life, therefore the use of information systems and software to support patients with epilepsy is a promising trend in electronic and mobile medicine. The aim of the study was to analyse data
Externí odkaz:
https://doaj.org/article/2ab83c9f4ca04a75888044e37707b7c3
Autor:
V. V. Arkhipov, T. S. Kheilo, E. G. Gladysheva, Yu. A. Danilogorskaya, M. R. Dzhavatkhanova, S. V. Snytko, I. V. Samorukova, M. V. Zhuravleva
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 1, Pp 78-90 (2022)
Microcirculation dysfunction plays a significant role in the development of post-COVID syndrome caused by SARS-CoV-2. However, there have been no studies on changes in microcirculation parameters during pharmacotherapy in patients with post-COVID syn
Externí odkaz:
https://doaj.org/article/2d765c71b5524fb2891729b3587b230b
Autor:
M. V. Zhuravleva, G. I. Gorodetskay, T. S. Reznikova, N. S. Vasyukova, V. V. Arkhipov, S. Yu. Serebrova
Publikováno v:
Антибиотики и Химиотерапия, Vol 66, Iss 9-10, Pp 39-53 (2022)
The aim of the study is to evaluate the clinical efficacy, safety, and impact of the complex metabolic neuroprotector on the patients’ quality of life (CMN) Cytoflavin in tablets, as well as in the course of stepwise pharmacotherapy of patients wit
Externí odkaz:
https://doaj.org/article/c7ae6b82807f44b6b383c9d9829e61e2
Autor:
E. A. Sokova, V. V. Arkhipov, O. A. Demidova, I. A. Mazerkina, T. V. Alexandrova, M. V. Zhuravleva
Publikováno v:
Безопасность и риск фармакотерапии, Vol 9, Iss 3, Pp 128-135 (2021)
The frequency of adverse drug reactions (ADRs) in older patients is approximately 11.0%, according to scientific literature. Antibiotics are the third largest group (19.5%) of medicinal products in terms of ADR frequency in geriatric patients. Beta-l
Externí odkaz:
https://doaj.org/article/9750ac6f3beb42a8a058548681526d08